However, the dependence of any RTG benefit on the functioning of the canonical TP53 suggests it is probable that other as yet undiscovered mechanisms of tumor suppression have also evolved in the elephant lineage, perhaps recruited from the array of cancer‐related genes that have been duplicated in the elephant genome (Vazquez & Lynch, 2021). The gene discussed is TP53; the disease is cancer.